No Record Found
Sector
PharmaceuticalsOpen
₹381Prev. Close
₹385.4Turnover(Lac.)
₹1,737.08Day's High
₹399.9Day's Low
₹376.0552 Week's High
₹40552 Week's Low
₹208Book Value
₹23.63Face Value
₹1Mkt Cap (₹ Cr.)
4,318.29P/E
97.11EPS
4.09Divi. Yield
0.17No Record Found
Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|---|
Equity Capital | 10.9 | 7.26 | 7.26 | 7.26 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 237.49 | 194.11 | 141.88 | 96.06 |
Net Worth | 248.39 | 201.37 | 149.14 | 103.32 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 90.56 | 85.12 | 38.79 | 35.69 |
yoy growth (%) | 6.38 | 119.39 | 8.7 | 9.4 |
Raw materials | -15.37 | -11.33 | -2.15 | -1.48 |
As % of sales | 16.97 | 13.31 | 5.55 | 4.16 |
Employee costs | -7.11 | -6.43 | -4.45 | -4.41 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 40.88 | 31.25 | 4.83 | 4.88 |
Depreciation | -1.73 | -1.36 | -1.14 | -1.11 |
Tax paid | -10.7 | -7.58 | -0.97 | -0.5 |
Working capital | 34.58 | 16.25 | 0.88 | 3.46 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 6.38 | 119.39 | 8.7 | 9.4 |
Op profit growth | 26.67 | 410.27 | 3.15 | -0.1 |
EBIT growth | 30.09 | 512.27 | -0.7 | 5.32 |
Net profit growth | 27.47 | 512.18 | -11.65 | -5.44 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,640.2 | 78.98 | 3,93,418.96 | 753.53 | 0.98 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,028 | 68.48 | 1,59,985.97 | 557 | 0.5 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,592.8 | 24.9 | 1,28,659.07 | 1,303.13 | 1 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,647.4 | 62.1 | 1,23,442.43 | 551 | 0.16 | 2,567 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,600.1 | 59.31 | 1,07,334.24 | 412.76 | 0 | 2,541.36 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Director
Dinesh S Patel
Managing Director
Sachin D Patel
Independent Non Exe. Director
VIJAY GOPI KISHAN AGARWAL
Independent Non Exe. Director
Kirandeep Madan
Independent Non Exe. Director
Siddharth Y Kusumgar
Company Sec. & Compli. Officer
RAHUL DWARAKA SONI
Independent Director
Hitesh Dharmasinh Gajaria
Additional Director
NIHAR AJAY PARIKH
69/C GIDC Industrial Estate,
Valsad Dist,
Gujarat - 396195
Tel: 91-260-2430027
Website: http://www.gtbl.in
Email: gtblmumbai@gtbl.in; admin@gtbl.co.in
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Compan...
Read More
Reports by Gujarat Themis Biosyn Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.